Wednesday, June11—Abnormal and disfiguring blood vessels growths in infants that also known as hemangiomas can be shrunk by a blood pressure drug, a new study suggests.
In two infants who had hemangioma, propranolol was used to treat heart conditions and it was found by the French researchers that the color and size of the hemangioma was diminished in both babies just in a day.

“We have accidentally found that propranolol could reduce the growth phase of hemangioma in these two babies,” stated Dr. Christine Leaute-Labreze of the department of pediatric dermatology at Bordeaux Children’s Hospital in France.

In the June 12 publication of the New England Journal of Medicine, the results of the study are going to be published.

Hemangiomas are often observed as red lesions in the top layers of the skin but sometimes they grow much deeper in the skin. They can spoil appearance but they are noncancerous.

According to Dr. Robin Gehris who is chief of pediatric dermatological surgery at Children’s Hospital of Pittsburg “The natural history of hemangiomas is that they act same placental tissue and most of them grow around nine months. She further told that most of them disappear by the age of 10.

Treatment is often given when hemangioma grows near the eye, airway or mouth as stated by Gehris. Corticosteroid is considered a usual treatment for serious hemangiomas and vincristine and interferon are other used drugs in this connection.

Propranolol belongs to beta blockers group of medications that are mostly used to lower down the blood pressure. People with diabetes, heart blockage and asthma are not suggested Beta blockers. There wasn’t any serious side effect noticed from propranolol in the infants but some were experienced with low blood pressure, stated Dr. Christine Leaute-Labreze.

Related links

Hemangiomas

Infants’ Hemangiomas may be shrunk by Beta Blocker

This article is the property ofhttp://www.healthhype.com
Copying and publishing any article from our site is strictly NOT allowed

  • Share/Save/Bookmark